Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol.

Abstract

BACKGROUND AND PURPOSE:

Cerebral infarction is a major cause of death or decreasing activities of daily living. This study aimed to investigate the efficacy of commonly used antiplatelet drugs on stroke and motor and cognitive functions in relation to oxidative stress markers and insulin-like growth factor 1 receptor (IGF-1R).

METHODS:

Stroke-prone spontaneously hypertensive rats were treated with vehicle, aspirin, clopidogrel, and cilostazol from 8 to 10 weeks of age. Physiological parameters, regional cerebral blood flow, and serum lipids were examined. Motor and cognitive functions were evaluated weekly by the Rotorod and water maze task. Spontaneous infarct volume, oxidative stress markers for lipid, protein, and DNA at the ischemic boundary zone of spontaneous infarction, and the IGF-1R-positive cell ratio in the hippocampus were immunohistochemically examined in brain sections. IGF-1Rβ expression in the hippocampus was assessed by Western blotting.

RESULTS:

The antiplatelet drugs, cilostazol and clopidogrel, reduced the spontaneous infarct volume more than aspirin. Only cilostazol improved motor and cognitive functions with a significant increase (P<0.05) in the memory-related IGF-1R-positive ratio and IGF-1Rβ expression in the hippocampus. Cilostazol reduced the 4 oxidative stress markers in affected neurons in stroke-prone spontaneously hypertensive rats regardless of blood pressure, regional cerebral blood flow, or serum lipid levels.

CONCLUSIONS:

The present results suggest that a possible pleiotropic effect of cilostazol resulted in the reduction of spontaneous infarct volume and preservation of motor and spatial cognitive functions. The increase of IGF-1R-positive cells in the hippocampal CA1 region could partly explain the preservation of spatial cognitive function in stroke-prone spontaneously hypertensive rats.

• Authors: Yoshio Omote, Kentaro Deguchi, FengFeng Tian, Hiromi Kawai, Tomoko Kurata, Toru Yamashita, Yasuyuki Ohta, Koji Abe
• Journal: Stroke (Stroke) Vol. 43 Issue 6 Pg. 1639-46 (Jun 2012) ISSN: 1524-4628 [Electronic] United States
• PMID: 22492522 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers
• Nerve Tissue Proteins
• Platelet Aggregation Inhibitors
• Tetrazoles
• Clopidogrel
• Receptor, IGF Type 1
• Cilostazol
• Ticlopidine
• Aspirin

Topics

• Animals
• Aspirin (pharmacology)
• Biomarkers (metabolism)
• Cerebral Infarction (drug therapy, metabolism)
• Cilostazol
• Clopidogrel
• Hippocampus (metabolism)
• Male
• Nerve Tissue Proteins (metabolism)
• Oxidative Stress (drug effects)
• Platelet Aggregation Inhibitors (pharmacology)
• Rats
• Rats, Inbred SHR
• Receptor, IGF Type 1 (biosynthesis)
• Tetrazoles (pharmacology)
• Ticlopidine (analogs & derivatives, pharmacology)